How the Mental Health Industry Creates Disease, Works with Big Pharma

Email Print
FacebookTwitterShare

We spend a lot of time at NaturalSociety talking about Big Pharma and their role in the health care industry. These huge pharmaceutical companies make billions every single year by perpetuating a culture of dis-ease and illness. They exaggerate conditions, offer their solutions as the only viable treatments, and essentially market disease to the American people. But they aren’t acting alone. Some of their biggest sellers are drugs created to treat mental health issues, diseases, and symptoms. Doctors and professionals within the mental health industry, therefore, act as their top salespeople.

Mike Bundrant is the host of Mental Health Exposed, a radio program from our friends at Natural News. He is a former mental health counselor and had an inside look at how the system works. as Bundrant points out, the system has some “dirty secrets”.

“The conventional mental health system is a cruel joke,” he writes for Natural news. “It’s ugly.”

Bundrant and others like him say the mental health industry is just as dirty as Big Pharma itself, creating conditions and “curing” with prescriptions. This means many counselors and psychiatrists are interested in treating mental illness with one solution—drugs.

The Mental Health Industry’s Dirty Secrets

We’ve seen this issue arise more so in the last 2 decades than ever before. Through the Diagnostic and Statistical Manual of Mental Disorders (essentially the bible of mental health for psychiatrists), hundreds of disease have essentially been ‘created’ and reclassified. Because of this, mental health ‘issues’ are skyrocketing and more individuals are on antipsychotic drugs than ever. Not surprisingly, as much as 70% of psychiatrists involved in the DSM have financial ties to drug companies.

“The bottom line is that it’s about the bottom line. So many clients, so much money. Keep the practices full, the insurance companies appeased and the revolving door turning.”

Read the rest of the article

Email Print
FacebookTwitterShare